Total Payments
$5,065
2024 Payments
$234.67
Companies
19
Transactions
51
Medicare Patients
6,386
Medicare Billing
$512,142
Payment Breakdown by Category
Food & Beverage$5,065 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,065 | 51 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AbbVie Inc. | $1,120 | 11 | $0 (2023) |
| Janssen Scientific Affairs, LLC | $579.38 | 5 | $0 (2021) |
| Lilly USA, LLC | $437.19 | 4 | $0 (2022) |
| Amgen Inc. | $418.50 | 4 | $0 (2018) |
| Regeneron Healthcare Solutions, Inc. | $352.71 | 3 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $337.86 | 3 | $0 (2017) |
| Ortho Dermatologics, a division of Bausch Health US, LLC | $248.87 | 3 | $0 (2021) |
| Bayer HealthCare Pharmaceuticals Inc. | $195.10 | 3 | $0 (2018) |
| PFIZER INC. | $179.83 | 2 | $0 (2022) |
| E.R. Squibb & Sons, L.L.C. | $177.56 | 2 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $234.67 | 2 | Regeneron Healthcare Solutions, Inc. ($125.23) |
| 2023 | $575.34 | 5 | Arcutis Biotherapeutics, Inc. ($146.94) |
| 2022 | $796.90 | 8 | Lilly USA, LLC ($234.60) |
| 2021 | $491.14 | 5 | Janssen Scientific Affairs, LLC ($123.07) |
| 2020 | $100.14 | 1 | AbbVie Inc. ($100.14) |
| 2019 | $651.86 | 6 | AbbVie, Inc. ($234.28) |
| 2018 | $617.54 | 7 | Janssen Scientific Affairs, LLC ($224.02) |
| 2017 | $1,598 | 17 | AbbVie, Inc. ($422.21) |
All Payment Transactions
51 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/05/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $125.23 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 09/17/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $109.44 | General |
| 05/09/2023 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $122.31 | General |
| Category: Dermatology | ||||||
| 04/11/2023 | Arcutis Biotherapeutics, Inc. | — | Food and Beverage | In-kind items and services | $146.94 | General |
| 03/14/2023 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $90.96 | General |
| 02/14/2023 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $122.31 | General |
| Category: DERMATOLOGY | ||||||
| 01/10/2023 | AbbVie Inc. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $92.82 | General |
| Category: IMMUNOLOGY | ||||||
| 12/13/2022 | Lilly USA, LLC | — | Food and Beverage | Cash or cash equivalent | $123.98 | General |
| 11/09/2022 | Sun Pharmaceutical Industries Inc. | ILUMYA (Biological), Winlevi | Food and Beverage | In-kind items and services | $109.39 | General |
| Category: Dermatology | ||||||
| 08/09/2022 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $107.78 | General |
| Category: DERMATOLOGY | ||||||
| 07/12/2022 | UCB, Inc. | — | Food and Beverage | In-kind items and services | $85.55 | General |
| 06/14/2022 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $84.98 | General |
| Category: IMMUNOLOGY | ||||||
| 05/03/2022 | Lilly USA, LLC | — | Food and Beverage | In-kind items and services | $110.62 | General |
| 04/29/2022 | PFIZER INC. | CIBINQO (Drug) | Food and Beverage | In-kind items and services | $71.72 | General |
| Category: Inflammation & Immunology | ||||||
| 03/08/2022 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $102.88 | General |
| Category: IMMUNOLOGY | ||||||
| 12/15/2021 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $86.60 | General |
| 10/13/2021 | Janssen Scientific Affairs, LLC | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $123.07 | General |
| Category: Immunology | ||||||
| 09/15/2021 | Ortho Dermatologics, a division of Bausch Health US, LLC | ARAZLO (Drug) | Food and Beverage | In-kind items and services | $92.06 | General |
| Category: Dermatology | ||||||
| 08/10/2021 | Lilly USA, LLC | — | Food and Beverage | In-kind items and services | $106.68 | General |
| 07/13/2021 | AbbVie Inc. | HUMIRA (Biological) | Food and Beverage | In-kind items and services | $82.73 | General |
| Category: IMMUNOLOGY | ||||||
| 01/14/2020 | AbbVie Inc. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $100.14 | General |
| Category: IMMUNOLOGY | ||||||
| 12/10/2019 | AbbVie, Inc. | Humira (Biological) | Food and Beverage | In-kind items and services | $109.28 | General |
| Category: Immunology | ||||||
| 11/12/2019 | AbbVie, Inc. | Skyrizi (Biological) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Immunology | ||||||
| 08/14/2019 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $123.98 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 07/09/2019 | Ortho Dermatologics, a division of Bausch Health US, LLC | DUOBRII (Drug) | Food and Beverage | In-kind items and services | $60.84 | General |
| Category: DERMATOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 1,605 | 2,963 | $823,499 | $132,659 |
| 2022 | 15 | 1,713 | 3,123 | $759,113 | $136,117 |
| 2021 | 15 | 1,675 | 2,989 | $699,870 | $143,479 |
| 2020 | 15 | 1,393 | 2,484 | $489,866 | $99,887 |
Total Patients
6,386
Total Services
11,559
Medicare Billing
$512,142
Procedure Codes
61
All Medicare Procedures & Services
61 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 375 | 568 | $201,072 | $37,289 | 18.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 137 | 191 | $95,882 | $18,174 | 19.0% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 258 | 382 | $123,386 | $15,424 | 12.5% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 143 | 171 | $67,716 | $13,010 | 19.2% |
| 11104 | Punch biopsy, first skin growth | Office | 2023 | 82 | 92 | $43,976 | $9,614 | 21.9% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 94 | 102 | $45,492 | $8,095 | 17.8% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 190 | 1,075 | $118,943 | $5,816 | 4.9% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 123 | 131 | $28,820 | $5,789 | 20.1% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 63 | 97 | $19,594 | $4,218 | 21.5% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 23 | 29 | $19,923 | $3,982 | 20.0% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2023 | 12 | 13 | $15,626 | $3,078 | 19.7% |
| 17261 | Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm | Office | 2023 | 27 | 30 | $17,070 | $3,073 | 18.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 22 | 22 | $9,548 | $1,861 | 19.5% |
| 17271 | Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 0.6-1.0 cm | Office | 2023 | 11 | 12 | $7,944 | $1,480 | 18.6% |
| 11105 | Punch biopsy, each additional skin growth | Office | 2023 | 16 | 19 | $4,389 | $970.17 | 22.1% |
| 99451 | Telephone, internet, or electronic health record assessment and management with written report by consulting physician, at least 5 minutes | Office | 2023 | 29 | 29 | $4,118 | $785.70 | 19.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 378 | 540 | $185,941 | $36,017 | 19.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 170 | 248 | $120,536 | $22,844 | 19.0% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 275 | 414 | $130,734 | $15,882 | 12.1% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 162 | 187 | $74,052 | $13,591 | 18.4% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 111 | 125 | $54,728 | $10,136 | 18.5% |
| 11104 | Punch biopsy, first skin growth | Office | 2022 | 83 | 88 | $42,160 | $8,533 | 20.2% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 219 | 1,143 | $32,474 | $6,082 | 18.7% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 113 | 128 | $27,203 | $4,979 | 18.3% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2022 | 73 | 101 | $20,402 | $4,302 | 21.1% |
About Dr. Marc Silverstein, M.D
Dr. Marc Silverstein, M.D is a Dermatology healthcare provider based in Sacramento, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/14/2006. The National Provider Identifier (NPI) number assigned to this provider is 1104869155.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Marc Silverstein, M.D has received a total of $5,065 in payments from pharmaceutical and medical device companies, with $234.67 received in 2024. These payments were reported across 51 transactions from 19 companies. The most common payment nature is "Food and Beverage" ($5,065).
As a Medicare-enrolled provider, Silverstein has provided services to 6,386 Medicare beneficiaries, totaling 11,559 services with total Medicare billing of $512,142. Data is available for 4 years (2020–2023), covering 61 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatology
- Location Sacramento, CA
- Active Since 06/14/2006
- Last Updated 03/29/2013
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1104869155
Products in Payments
- Humira (Biological) $531.49
- Enbrel (Biological) $418.50
- Tremfya (Drug) $348.67
- COSENTYX (Biological) $337.86
- SKYRIZI (Biological) $295.84
- DUPIXENT (Biological) $249.21
- Finacea (Drug) $195.10
- Skyrizi (Biological) $125.00
- TREMFYA (Drug) $123.07
- OPZELURA (Drug) $122.31
- VTAMA (Drug) $122.31
- ILUMYA (Biological) $109.39
- EUCRISA (Drug) $108.11
- ADBRY (Biological) $107.78
- STELARA (Biological) $107.64
- DUPIXENT DUPILUMAB INJECTION (Biological) $103.50
- RHOFADE (Drug) $103.14
- DISEASE STATE (Drug) $100.00
- ONEXTON (Drug) $95.97
- ARAZLO (Drug) $92.06
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Sacramento
Dr. Raja Sivamani, M.d., M.s., A.h.e, M.D., M.S., A.H.E
Dermatology — Payments: $1.3M
Dermatology $1.3M
Dr. Emil Tanghetti, M.d, M.D
Dermatology — Payments: $1.0M
Dermatology $1.0M
Jacqueline Calkin, M.d, M.D
Dermatology — Payments: $130,291
Dermatology $130,291
Dr. Emanual Maverakis, M.d, M.D
Dermatology — Payments: $52,284
Dermatology $52,284
Alison Boudreaux, M.d, M.D
Dermatology — Payments: $46,728
Dermatology $46,728
Mirza Alikhan, Md, MD
Dermatology — Payments: $30,111
Dermatology $30,111